Flagship Harbor Advisors LLC Sells 75 Shares of Align Technology, Inc. $ALGN

Flagship Harbor Advisors LLC reduced its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 2.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,147 shares of the medical equipment provider’s stock after selling 75 shares during the period. Flagship Harbor Advisors LLC’s holdings in Align Technology were worth $596,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its holdings in Align Technology by 2,900.0% during the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 174 shares during the last quarter. SVB Wealth LLC bought a new position in Align Technology during the 1st quarter valued at about $36,000. Farther Finance Advisors LLC lifted its holdings in Align Technology by 42.2% during the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 92 shares during the last quarter. Mather Group LLC. lifted its holdings in Align Technology by 375.0% during the 1st quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 345 shares during the last quarter. Finally, Covestor Ltd lifted its holdings in Align Technology by 18.8% during the 1st quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock valued at $78,000 after purchasing an additional 78 shares during the last quarter. 88.43% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $200.00 price target (up from $190.00) on shares of Align Technology in a report on Thursday. Jefferies Financial Group raised their price objective on shares of Align Technology from $140.00 to $155.00 in a research report on Thursday. Morgan Stanley raised their price objective on shares of Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a research report on Thursday. Leerink Partners raised their price objective on shares of Align Technology from $172.00 to $189.00 in a research report on Thursday. Finally, Stifel Nicolaus set a $200.00 price objective on shares of Align Technology in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $177.27.

Align Technology Price Performance

Shares of NASDAQ:ALGN opened at $137.88 on Friday. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19. The company has a 50 day moving average of $133.23 and a 200-day moving average of $161.81. The stock has a market cap of $9.99 billion, a price-to-earnings ratio of 26.72, a P/E/G ratio of 1.49 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, topping the consensus estimate of $2.38 by $0.23. Align Technology had a net margin of 9.50% and a return on equity of 14.06%. The company had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. During the same quarter in the previous year, the company earned $2.35 EPS. Align Technology’s revenue was up 1.8% on a year-over-year basis. Align Technology has set its Q4 2025 guidance at EPS. Equities research analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its Board of Directors has approved a stock repurchase program on Tuesday, August 5th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.